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Abstract
Background: We investigated the determinants of trajectories of physical symptoms related to lung cancer (a quality
of life [QOL] aspect) and self-efficacy among patients with non-small cell lung cancer (NSCLC). It was hypothesized that
gender and family cancer history in first-degree relatives would have synergistic effects on QOL-lung cancer specific
symptoms and self-efficacy. Women with family cancer history were expected to be at risk of poorer adjustment.
Methods: Quantitative, longitudinal design was applied. Participants provided their responses at 3–4 days after surgery,
1-month follow-up, and 4-month follow-up. We recruited 102 in-patients (men: 51%) with NSCLC who underwent
surgery aimed at removing a lung tumor. Self-report data were collected with QLQ-LC13 and a scale for self-efficacy for
managing illness.
Results: Mixed-models analysis indicated that trajectories of physical quality of life (symptoms of lung cancer) as well
as self-efficacy were unfavorable among women with family cancer history.
Conclusions: Among NSCLC patients, gender and family cancer history may be considered basic screening criteria for
identifying groups of patients at risk for poorer physical QOL (higher level of physical symptoms related to lung cancer)
and lower incline of self-efficacy after cancer surgery.
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Background
Lung cancer is accounting for the largest number of
cancer-related deaths in the European Union [1]. Besides
poor survival rates [1], lung cancer and lung cancer sur-
gery may cause major changes in some areas of quality of
life (QOL). For example, patients with the most frequent
form of lung cancer, non-small cell lung cancer (NSCLC),
report a decline in physical function across six months
after surgery [2, 3]. Lung-cancer specific symptoms such
as pain, fatigue, dyspnea, and coughing are reported fre-
quently [3]. Additionally, there are subsets of patients who
report persistently poor QOL across months after surgery
[3]. Importantly, levels of physical QOL are significantly
associated with overall survival: A 10% decline in physical
QOL during the first six months after surgery is associated
with an 18% increased risk of death [4].
Discovering factors explaining a decline in physical as-
pects of QOL would help to identify patients who are at
risk of poor post-surgery adjustment. Consequently,
screening and identifying those at risk for poorer physical
functioning would be possible and psychosocial interven-
tions could target those patients with NSCLC who need
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them most. Our study aims at investigating the potential
risk factors that may be easily and early detected, such as
family history of cancer and gender, and their effects on
changes in QOL and a psychosocial resource variable,
self-efficacy.
The family history of cancer is usually defined in the
context of immediate family, that is having parents or sib-
lings with cancer [5, 6]. This construct reflects multiple
physiological and psychological factors such as heritability,
perceived risk for cancer, as well as psychosocial stress re-
ferring to providing support/care for a family member
with cancer [5–7]. The role of family history of cancer on
patients’ functioning was investigated mainly in the con-
text of distress or emotional indices of QOL. High distress
levels are particularly likely if individuals with family can-
cer history cared for a cancer patient or if they lost a fam-
ily member due to cancer [8]. A combination of having
family cancer history and being diagnosed with cancer
was the best predictor of symptoms indicating serious
mental health risk [7]. Additionally, being diagnosed with
lung cancer constitutes a traumatic experience [9].
Although the effects of an interaction between family
cancer history and own cancer diagnosis on mental health
and distress are well established in the context of cancers
of lung or breast [10, 11], the effects of such interaction
on physical functioning or physical symptoms were not
thoroughly investigated. Researchers indicated that indi-
viduals who perceive themselves as at higher risk for can-
cer due to family cancer history experience a significant
increment of distress [10, 11]. Elevated distress levels, in
turn, explain poorer physical QOL among cancer patients
[12, 13]. Thus, a larger decline in physical aspects of QOL
among patients with NSCLC with family cancer history
may be expected, compared to patients without family
cancer history.
Conservation of resources (COR) theory proposes a dy-
namic approach to adaptation to stressful events [14, 15],
including resource change as a central mechanism. In par-
ticular, this theory suggests that being exposed to severe
stressors causes a loss or depletion of individual’s re-
sources, such as self-efficacy. Self-efficacy is one of the key
personal psychosocial resources operating when individual
is exposed to demanding situations [16]. Social cognitive
theory [17] suggests that self-efficacy refers to the confi-
dence that one can employ the skills necessary to cope
with stress and mobilize one's resources required to meet
the situational demands. Self-efficacy determines physical
and mental health [17]. Self-efficacy constitutes a source
of emotional or social well-being rather than its outcome
[17]. People diagnosed with cancer who observe distress
and a decline of physical function of their cancer-afflicted
family members may harbor pessimistic beliefs about the
course of their own cancer [7]. In line with COR [14, 15]
it may be assumed that an exposure to stressful events
(such as having a family member diagnosed with cancer)
would cause a depletion of self-efficacy.
The beneficial role of behavior-specific self-efficacy as a
source of QOL or a determinant of health behaviors was
shown in studies with mixed samples of cancer patients
[18–20], yet its role in adjustment among lung cancer has
been rarely investigated. As indicated, lung cancer has its
specificity, related to a high decline in physical aspects of
QOL/high level of symptoms and low survival rates [1, 2].
Two cross-sectional studies by Porter et al. [21] and Por-
ter, Keefe, Garst, McBride, and Baucom [22] found that
self-efficacy referring to symptom and illness management
was related to lower physical symptoms and better phys-
ical QOL among lung cancer patients. However, a longitu-
dinal investigation showed that pre-surgery self-efficacy
for managing illness was unrelated to physical aspect of
QOL at 3-month follow-up [23]. Importantly, theories
[17] and research [21–23] consider self-efficacy to
form a crucial predictor of QOL or other well-being
outcomes. Furthermore, trajectories in self-efficacy
(such as post-surgery increase or decline over time)
represent a meaningful main outcome, which may be con-
sidered independently from QOL trajectories [24]. In sum,
among lung cancer patients time-lagged associations be-
tween self-efficacy and physical QOL are uncertain. The
trajectories of these two variables may represent inde-
pendent outcomes of post-surgery adaptation. Further-
more, the determinants of low levels of self-efficacy or risk
factors for low self-efficacy among lung cancer patients
are unclear and require further investigation.
The majority of studies testing the effects of gender on
QOL among patients with lung cancer showed that men
and women do not differ in physical QOL indices (for a
review see [3]). Although gender may not affect QOL dir-
ectly, it may explain differences in QOL between people
with and without family history of cancer. Women are
more likely than men to uptake a caregiver role if they
have a parent or a sibling with cancer (for a review see
[25]). Compared to men caregivers, women caregivers are
more likely to report higher stress levels and more nega-
tive experiences in relation to caregiving, perceive caregiv-
ing as an obligation and duty rather than their private
choice, spend more hours on caregiving tasks, and conse-
quently report higher burden and lower QOL [25].
Although most of the comparisons were performed for
emotional functioning or mental health, gender differ-
ences (unfavorable for women caregivers) were also found
for the physical aspect of functioning [26]. In sum, an
interaction between gender and having family cancer
history may determine a decline in personal resources
(such as self-efficacy) due to high stress levels as well as
lower levels of QOL, also in its physical domain.
We investigated the determinants of trajectories in
physical symptoms related to lung cancer (a QOL aspect)
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and self-efficacy, measured at 3–4 days after surgery, 1-
month follow-up, and 4-month follow-up. It was hypothe-
sized that gender and immediate family cancer history
would have synergistic effects on symptoms reported by
patients with NSCLC. Women with family cancer history
were expected to be at risk of poorer physical functioning
and poorer self-efficacy.
QOL-lung cancer specific symptoms may be predicted
by patient’s emotional well-being and mental health [27].
Therefore, our investigation of the trajectories of QOL-
lung cancer specific symptoms will account for potential
confounders such as emotional QOL and social QOL.
Furthermore, as levels and trajectories of self-efficacy
among cancer patients may depend on socio-
demographic variables such as age [28] or cancer-related
variables (e.g., the type of treatment) [28], these variables
will be accounted for in an investigation of self-efficacy
trajectories. Although some models discussing the role
of self-efficacy in adjustment to cancer would suggest
that emotional or social QOL may explain self-efficacy
[28], the majority of research and theoretical approaches
[17, 18, 21–23] would posit that self-efficacy explains
emotional or social QOL instead of assuming that self-
efficacy is determined by QOL. Therefore, controlling
for baseline emotional and social QOL while explaining
self-efficacy trajectories over time may be unnecessary.
Methods
Participants
Participants were 102 men (n = 52; 51%) and women
(n = 50; 49%) who underwent surgery aimed at removing
a lung tumor, non-small cell lung cancer (NSCLC). All pa-
tients provided their responses at Time 1 (T1; 3–4 days
after surgery) and Time 2 (T2, 1-month follow-up); two
participants died before Time 3 (T3; 4-month follow-up).
There was no other attrition. Analyses were conducted in
the sample of the completers.
Respondents were 22–79 years old (M = 59.31, SD =
10.17). The majority of NSCLC patients were married or
in a long-term relationship (70%), 15% were widowed,
13% defined themselves as single, and 2% were divorced.
The minority had a university degree (20%); 80% had a
high school education or lower levels of education.
Procedures
Participants were recruited among inpatients who re-
ceived NSCLC-related surgery in the Lower Silesia Cen-
ter for Lung Diseases, which is the main regional center
for lung cancer treatment in South-West Poland. Exclu-
sion criteria were: being hospitalized for other reasons
than lung tumor removal surgery, declaring an inability
to participate due to difficulties to breathe or speak,
staying in the intensive care unit or a high dependency
recovery unit for more than 72 h after the surgery.
Patients who had a lung surgery aiming at tumor re-
moval were approached and invited to take part in the
study, informed about its aims and design. After identi-
fying the potential participants and receiving their con-
sent, the experimenter consulted the ward surgeon
about the type of surgery and diagnosis. Only patients
with NSCLC who received lobectomy or wedge resec-
tion were included. The experimenters were certified
clinical psychologists. After each measurement point, all
participants were offered psychological consultation.
However, no patient made an appointment to take part
in such consultations.
All participants provided their informed written con-
sent, and procedures securing respondents’ anonymity
were applied. The study was approved by the Internal
Review Board at the first author’s institution.
Measurement of quality of life: lung cancer-related phys-
ical symptoms
QLQ-LC13 [29], measuring QOL domain of lung cancer-
related symptoms, was used. It includes 12 items referring
to lung cancer-associated symptoms (cough, haemoptysis,
dyspnea, and site-specific pain), treatment-related side ef-
fects (sore mouth, dysphagia, peripheral neuropathy, and
alopecia). Although the standard approach to scoring
would be to combine three dyspnea items and use the
remaining items as nine separate symptom subscales [29],
this strategy is not based on a theoretical/empirical ap-
proach proposing distinct constructs and it results in
multiplying (related) outcomes. Therefore, in the present
study we combined the 12 symptoms into one index of
QOL referring to physical functioning related to lung can-
cer. The scale had good reliability with α of .71, .78, and
.74 at T1, T2, and T3 respectively.
Scores of the indices obtained with QLQ-LC13 range
from 0 to 100. High scores for symptoms scales repre-
sent a high level of symptomatology [30]. A difference of
5–10 points in the scores represents a small change, 10–
20 points a moderate change and greater than 20 points
a large, clinically significant change from the patient’s
perspective [31].
Measurement of self-efficacy for managing illness
This self-efficacy scale was based on a self-efficacy meas-
ure used previously in the context of dealing with lung
cancer [22]. We used a total of six items from the scale
of Porter et al. [22], referring to self-efficacy for man-
aging pain (two items), symptoms (two items), and func-
tion (two items). The item example was ‘How certain
are you that you can manage your daily activities even if
you feel pain due to lung cancer and its treatment?’ or
‘How certain you are that you can do something to help
yourself even if you are feeling blue due to your illness
and its consequences?’ Additionally, we developed seven
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items referring to patients’ ability to cope with conse-
quences related to lung cancer-associated symptoms
(cough, haemoptysis, dyspnea and site-specific pain), in-
cluded in QLQ-LC13. For example, patients were asked
‘How certain are you that you can deal with challenges
related to your illness and its consequences even if you
are short of breath when you walk?’, ‘How certain are
you that you can deal with challenges related to your ill-
ness and its consequences even if you feel pain in your
shoulder/back?’. Six items from the scale by Porter et al.
[22] and seven items developed for this study were com-
bined into a single scale, as all items loaded on one fac-
tor obtained in a principal component analysis, with
factor loadings ranging from .37 to .70. Responses were
given on 5-point scale ranging from 1 (definitely not) to
5 (exactly true). Reliability of the scale was good, with
Cronbach’s α = .76 at T1, α = .82 at T2, and α = .80 at T3.
Modest associations with scores of the General Self-
Efficacy Scale [32] were found, with r of .30 (T1), .27
(T2), and .31 (T3), all ps < .01.
Measurement of family history of cancer
Patients were asked to indicate if any of their first-degree
relatives (a parent, brother, sister, or child) have ever been
diagnosed with cancer and treated for cancer. Patients
were asked to refer to any type of cancer, occurring any
time. Measures using similar formula were applied in pre-
vious research (cf. [7]). This general, nominal index with
0–1 values was chosen as it represented the best fit for the
hypotheses and analytical strategy investigating if gender
and family cancer history differentiate trajectories of
QOL-lung cancer symptoms and self-efficacy.
Three out of 102 patients were unsure about family
cancer history, but the majority (54%) of the remaining
99 patients reported family cancer history.
Measurement of covariates
Social and emotional aspects of QOL were measured at
T1 with respective subscales of EORTC QLQ-C30 [30].
The responses are given on 5-point scales ranging from 1
(definitely not) to 5 (exactly true) and then recoded to a
scale ranging from 0 to 100 [30]. High scores for symp-
toms scales represent better functioning in respective
areas [30]. The subscale assessing emotional QOL
includes 4 items (e.g.,’ During the past week did you feel
depressed?’). Mean T1 scores were 71.75 (SD = 31.49).
The subscale assessing social QOL includes 2 items
(e.g.,’During the past week has your physical condition or
medical treatment interfered with your social activities?’).
Mean T1 scores were 79.83 (SD = 26.83). The reliability of
both measures was acceptable, with alpha of .61 and .51
for emotional and social subscales, respectively.
Statistical analysis
Using the SPSS 24 MIXED procedure, linear multilevel
models were computed with maximum likelihood (ML)
estimation [33] using family cancer history and gender
as the main predictors. We specified two outcomes
(QOL-lung cancer specific physical symptoms and self-
efficacy for managing illness) as level-1 dependent vari-
ables. Three time points nested in individuals represented
level-2 variables. We studied cross-level interactions to
determine the interrelationships between family cancer
history (coded as: +1 [with family cancer history], −1
[without family cancer history]), gender (coded as −1
[female], +1 [male]), and time (coded as: 0, 1, 2). The ana-
lysis explaining the changes in lung cancer-specific QOL
accounted for additional emotional QOL and social QOL.
The analysis explaining changes in self-efficacy accounted
for two covariates, age and surgery type (1 for lobectomy,
0 for segmentectomy). The time-invariant covariates, such
as age, emotional QOL, and social QOL were mean-
centered.
In a linear mixed-effects model, the responses from par-
ticipants are thought to be the sum of fixed and random
effects. The fixed effects are of primary interest, and ran-
dom effects contribute to the covariance structure of the
data. Adjustments for the covariance structure make the
results more accurate. Three patients were unsure
whether there has been any cancer diagnosis in their fam-
ily network. These were defined as missing values across
the analyses.
Based on medium-size effects observed in previous re-
search [23] we estimated that the sample securing ad-
equate power to obtain significant effects should include
101 participants. The estimation was done with G*Power
3.1.9.2 software.
Missing data for all variables were replaced using re-
gression (maximum likelihood estimation). In total,
0.07% of the values were replaced.
Results
Preliminary analyses
The majority reported that they never observed any lung
cancer symptoms (42%) or experienced some symptoms
in the year prior the surgery (37%), with remaining 21% of
participants indicating severe symptoms. Following tumor
stages were reported: 52% of t1 (tumor no larger than
3 cm), 15% of t2 (tumor of 3–7 cm; tumor involves the
main bronchus), 3% of t3 (tumor is larger than 7 cm, has
grown into the chest wall, the diaphragm, the mediastinal
pleura or parietal pericardium) whereas 31% of patients
were not certain about the stage of their tumor. The sur-
gery procedures included lobectomy (21%) and wedge re-
section or segmentectomy (79%). For all patients, it was
the first onset of lung cancer; all participants were less
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than 30 days since the consultation when the suspicion of
lung cancer was raised.
We evaluated the effects of stages of cancer and pa-
tients’ knowledge about their cancer stage on the study
variables. The stages of cancer were unrelated to cancer
in family, χ2(3, 73) = 3.72, p = .249. Patients who knew
their cancer stage did not differ in terms of family cancer
history from those who were unaware of their cancer
stage, χ2(1, 100) = 2.80, p = .095. Gender was unrelated to
patients’ knowledge of their cancer stage, χ2(1, 100) = 2.88,
p = .090. Women and men did not differ in the stages of
cancer, χ2(3, 73) = 2.30, p = .512. The patients who knew
the stage of their cancer did not differ from those who did
not know the stage in levels of self-efficacy and QOL
indicators across the measurement points, all Fs < 0.46,
ps > .500. More advanced stages of cancer were related to
lower QOL-lung cancer symptoms (i.e., higher symp-
toms), with r = .23 (p = .052) at T1, r = .31 (p = .009) at T2,
and r = .26 (p = .030) at T3. The stages of cancer were
unrelated to self-efficacy (rs from -.18 to -.06, ps > .098).
Correlations between the main study variables, that is
QOL (lung cancer-specific symptoms) and self-efficacy in-
dices at three measurement points are reported in Table 1.
Between-groups comparisons conducted at three meas-
urement points indicated that gender and family cancer
history had negligible or small effects on QOL-lung cancer
physical symptoms, but their effects on self-efficacy for
managing illness were significant and of small-to-
moderate size (Table 1). Cancer in family was unrelated to
participant’s gender, χ2 (1, 100) = 1.23, p = .268.
The effects of gender and family cancer history were
observed for QOL-lung cancer symptoms at T1 and
self-efficacy at T1 and T3 (Table 1). In particular, women
had poorer physical quality of life at T3, as indicated by
higher scores of QOL-lung cancer physical symptoms
(Cohen’s d = 0.52). Participants with family cancer history
had poorer physical quality of life at T1 (Cohen’s d = 0.52)
and T3 (Cohen’s d = 0.45). Across all three measurement
points, self-efficacy levels were lower for women and par-
ticipants with family cancer history (Cohen’s ds ranging
from 0.20 to 0.79).
The effects of time, gender, and family cancer history on
QOL-lung cancer specific symptoms
First, the analysis aimed at testing the synergistic effects
of gender and family cancer history on changes in QOL-
lung cancer physical symptoms, measured at 3–4 days
after surgery, 1-month follow-up, and 4-month follow-
up. Linear mixed models were computed with time
points nested in individuals, using QOL-lung cancer
physical symptoms at three time points as the level-1
dependent variable, patients family cancer history and
gender as level-2 variables, and emotional QOL and so-
cial QOL as covariates. Analyses were conducted first
without the interaction terms, and then repeated with
the interactions between gender, family cancer history
and time (Table 2).
The findings are presented in Table 2 and Fig. 1. The
intercept of 25.96 indicates the estimated initial status of
men with family history of cancer. This analysis was
controlled for initial emotional QOL (b = −0.16, t =
−3.68, p < .01) and social QOL (b = −0.14, t = −3.03, p
< .01), exerting two main effects. Time showed a de-
creasing overall trend (b = −7.61, t = −10.09, p < .01).
Gender (p = .93) was not associated with the initial levels
of QOL-lung cancer physical symptoms, but family his-
tory of cancer was (b = 2.97, t = 2.10, p = .04) which
means that patients who have reported having had a
family member with cancer also reported higher levels
of QOL-lung cancer symptoms. These findings were
qualified by a trend for a higher-order interaction of
cancer in family * time * gender (b = −1.32, t = −1.75, p
= .08) documenting a differential trajectory for men and
women across time and between groups with or without
cancer in family.
As presented in Fig. 1, lung cancer symptoms declined
over time in men with and without family cancer history.
A similar, declining trajectory was found among women
without family cancer history. However, women with
family cancer history reported a high level of lung cancer
symptoms at T1, followed by a decline at T2 and an in-
crease of symptoms at T3.
The effects of time, gender, and family cancer history on
self-efficacy
Next, the analysis aimed at testing the synergistic effects
of gender and family cancer history on changes in self-
efficacy for managing illness, measured at 3–4 days after
surgery, 1-month follow-up, and 4-month follow-up.
Again, linear mixed models were computed with time
points nested in individuals, using self-efficacy at three
time points as the level-1 dependent variable, patients’
family history of cancer and gender as level-2 variables,
and age and surgery type as covariates. Analyses were
conducted first without the interaction terms, and then
repeated with the interactions between gender, family
cancer history, and time (Table 3).
The findings on self-efficacy are presented in Table 3
and Fig. 2. The intercept of 3.91 indicates the estimated
initial status of men with family history of cancer. This
analysis was controlled for initial age (p = .17) and sur-
gery type (p = .21), both of which did not contribute sig-
nificantly to the equation. Time showed an increasing
overall trend (b = 0.42, t = 15.87, p < .01). Gender was as-
sociated with the initial status (b = 0.21, t = 4.92, p < .01),
meaning that men had higher self-efficacy. Regarding
the linear slope of self-efficacy, men showed a slower
rate of change as compared with women (b = −0.06, t =
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−2.15, p = .03). The family history of cancer was related to
self-efficacy (b = −0.08, t = −2.03, p = .04) which means
that patients with a family history of cancer reported
lower self-efficacy for managing illness. These findings
were qualified by the higher-order interaction of cancer in
family * time * gender (b = 0.06, t = 2.29, p = .02) which
documents a differential trajectory for men and women
across time and between groups with and without family
cancer history.
As presented in Fig. 2, men with and without family
cancer history presented similar self-efficacy changes over
time. In particular, self-efficacy levels markedly increased
from T1 to T2, and remained high and stable between T2
and T3. The increase of self-efficacy from T1 to T2 was
also found for women. However, although among women
without family cancer history there was an additional in-
crease from T2 to T3, self-efficacy remained relatively
stable from T2 to T3 (and markedly lower) among women
with family cancer history.
Discussion
The findings offer an insight into synergistic effects of
NSCLC patients’ gender and family cancer history on a
physical aspect of QOL (QOL-lung cancer specific
symptoms) and a personal resource variable, self-efficacy
for managing illness. A significant time * family cancer
history interaction was found for QOL-lung cancer spe-
cific symptoms. Furthermore, a trend for a significant
interaction of gender, family cancer history and time was
found for QOL-lung cancer specific symptoms. Overall,
a systematic decline in the level of lung-cancer-specific
Table 2 Linear mixed modeling: synergistic effects of time, gender, and family cancer history on QOL-lung cancer specific
symptoms
Parameter Estimate SE df t P 95% Confidence Intervals
Lower Bound Upper Bound
Results for QOL-lung cancer physical
symptoms: analysis with main effects
only (no interaction terms)
Intercept 26.28 1.43 162.03 18.36 <.01 23.45 29.10
Emotional QOL (covariate) −0.18 0.04 99.57 −4.11 <.01 −0.27 −0.09
Social QOL (covariate) −0.13 0.05 99.33 −2.83 .01 −0.23 −0.04
Family cancer history 2.22 1.24 99.44 1.79 .08 −0.24 4.68
Gender −0.62 1.33 99.68 −0.47 .64 −3.27 2.02
Time −7.52 0.76 122.15 −9.85 <.01 −9.03 −6.01
Results for QOL-lung cancer physical
symptoms: analysis with interaction terms
Intercept 25.96 1.40 164.12 18.60 <.01 23.21 28.72
Emotional QOL (covariate) −0.16 0.04 99.88 −3.68 <.01 −0.24 −0.07
Social QOL (covariate) −0.14 0.05 99.53 −3.03 <.01 −0.23 −0.05
Family cancer history 2.97 1.41 162.46 2.10 .04 0.18 5.76
Gender 0.13 1.49 155.71 0.09 .93 −2.80 3.07
Gender * Family cancer history −1.94 1.41 162.53 −1.38 .17 −4.73 0.84
Time −7.61 0.75 121.39 −10.09 <.01 −9.10 −6.11
Time * Family cancer history −0.62 0.75 121.39 −0.82 .41 −2.11 0.88
Time * Gender −0.74 0.75 121.38 −0.98 .33 −2.23 0.75
Time * Gender* Family cancer history −1.32 0.75 121.38 −1.75 .08 −2.81 0.17
Significant effects (p < .05) and trends for significant effects (p < .10) are marked in bold
Fig. 1 Trajectories of quality of life-lung cancer symptoms (QLQ-LC13
scores, Y axis) across three measurement points (1: 3–4 days after surgery,
2: 1-month follow-up, and 3: 4-month follow-up): Effects of gender and
family cancer history among patients with non-small cell lung cancer
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symptoms was observed among men and women with-
out family cancer history and among men with family
cancer history. However, women with family cancer his-
tory tended to have had a different trajectory of QOL-
lung cancer specific symptoms, with an initial decline
followed by an increase of symptoms. Additionally, a sig-
nificant interaction of gender, family cancer history, and
time explained self-efficacy trajectories. A systematic in-
crease of self-efficacy for managing illness was found for
men and women without family cancer history and
among men with family cancer history. However, the in-
cline of self-efficacy over time was markedly smaller
among women with family cancer history. Concluding,
among patients with lung cancer surgery, women with
family cancer history formed a group that was at-risk for
less favorable trajectories of QOL-lung cancer specific
symptoms and self-efficacy.
Our study extends the evidence obtained in previous
research which indicated effects of being diagnosed with
cancer and having family cancer history on mental
health outcomes [7, 9]. In particular, we show that syner-
gistic effects of being diagnosed with cancer and having
family cancer history may account for the role of the
third variable, gender. Furthermore, we show that these
synergistic effects are salient for trends in physical as-
pects of QOL, which are related to mortality among
Table 3 Linear mixed modeling: synergistic effects of time, gender, and family cancer history on self-efficacy
Parameter Estimate SE df t p 95% Confidence Intervals
Lower Bound Upper Bound
Results for self-efficacy for managing illness:
analysis with main effects only (no interaction terms)
Intercept 3.89 0.05 196.43 84.88 <.01 3.80 3.98
Age (covariate) <−0.01 <0.01 108.64 −1.33 .19 −0.01 <0.01
Surgery type (covariate) 0.11 0.08 109.36 1.47 .14 −0.04 0.27
Family cancer history −0.07 0.03 108.91 −2.11 .04 −0.13 <0.01
Gender 0.15 0.03 108.91 4.61 <.01 0.09 0.22
Time 0.41 0.03 284.28 14.41 <.01 0.35 0.47
Results for self-efficacy for managing illness:
analysis with interaction terms
Intercept 3.91 0.05 469.47 86.70 <.01 3.82 3.99
Age (covariate) <−0.01 <0.01 689.34 −1.37 .17 −0.01 <0.01
Surgery type (covariate) 0.10 0.08 686.15 1.26 .21 −0.06 0.26
Family cancer history −0.08 0.04 442.34 −2.03 .04 −0.17 <0.01
Gender 0.21 0.04 444.84 4.92 <.01 0.12 0.29
Gender * Family cancer history −0.04 0.04 445.44 −0.85 .40 −0.12 0.05
Time 0.42 0.03 259.45 15.87 <.01 0.36 0.47
Time * Family cancer history 0.02 0.03 259.45 0.70 .49 −0.03 0.07
Time * Gender −0.06 0.03 259.45 −2.15 .03 −0.11 <−0.01
Time * Gender* Family cancer history 0.06 0.03 259.45 2.29 .02 0.01 0.11
Significant effects (p < .05) and trends for significant effects (p < .10) are marked in bold
Fig. 2 Trajectories of self-efficacy for managing illness (mean item
response, Y axis) across three measurement points (1: 3–4 days after
surgery, 2: 1-month follow-up, and 3: 4-month follow-up): Effects of
gender and family cancer history among patients with non-small cell
lung cancer. Self-efficacy mean item responses could range from 1
to 5. As the actual mean item responses were above 4, only values
above 4 are displayed in Y axis
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NSCLC patients [4]. Our findings may also help to ex-
plain a lack of effects of gender on physical QOL among
patients with lung cancer [3]. In line with previous re-
search [3] we found that direct effects of gender on the
physical aspect of QOL may be absent or very small.
However, gender produced a synergistic effect on phys-
ical aspect of QOL, together with family cancer history.
In sum, both gender and family cancer history need to
be accounted for in explaining QOL among patients
with lung cancer.
The underlying mechanisms, explaining the effects of
female gender and having an immediate family member
diagnosed with cancer, were not investigated in our
study. The synergistic effects of these two factors may
represent a high likelihood of being an informal care-
giver, which in turn may be a proxy of high stress levels
and negative experiences in relation to caregiving, longer
time spent on caregiving tasks, and burnout-related ex-
haustion [25, 26]. Another set of underlying mechanisms
may refer to cancer in the family (in contrast to other
mental or physical health issues). In particular, observing
distress and a decline of physical function of family
members with cancer may affect patients’ beliefs about
their own cancer, its treatment, and prognosis (cf. [5, 7]).
Additionally, having an immediate family member with
cancer influences one’s own perceived risk for cancer
and related distress [10]. Future studies need to clarify
the complex mediating mechanisms explaining the syn-
ergistic effects of gender and family cancer history.
This study has several limitations. Although three meas-
urement points were applied, they cover a relatively short
period after surgery related to NSCLC. Further observa-
tions, covering the year after surgery are needed to establish
if the observed trends are stable over longer periods. The
vast majority of the participants had less advanced stages of
NSCLC and they had either lobectomy or wedge resection/
segmentectomy. Trajectories observed among patients with
the most advanced stages of NSCLC and those with pneu-
monectomy may be different and no generalizations should
be made at this stage. The measurement of family cancer
history was very general and referred to any cancer in any
immediate family members, partners, or children. There-
fore, more detailed analyses investigating the type of cancer,
death due to cancer, time of illness and relationship with
family members with cancer could not be conducted. As
research evidence indicates that depression is a relevant risk
factor for poorer physical QOL in lung cancer patients [27]
this variable should be carefully controlled in further stud-
ies. Unfortunately, our study did not account for a measure
of depression. Our study did not account for potentially
relevant determinants of self-efficacy or QOL such as social
support [34]. Future research may need to further control
for potential effects of other social or personal resources.
Although our operationalization of family cancer history
allows for comparisons with other studies testing the role
of this variable [7], it did not allow us for testing the effects
of providing care to other family members or members
with other chronic and severe illnesses. Future research
needs to clarify if the observed effects of family history refer
to cancer in the family (and not other illnesses) and to im-
mediate family (versus next of kin, any relative).
Conclusion
The results point out that female NSCLC patients with
family cancer history constitute a group that is at risk for
poorer post-surgery adjustment in terms of QOL-lung
cancer specific symptoms and selected psychosocial re-
sources, such as self-efficacy. As a decline in physical
QOL is related with an increased risk of mortality among
patients with lung cancer [4], the findings may have impli-
cation for clinical practice. Among people with NSCLC,
women with family cancer history should be the primary
target for psychosocial interventions. Identifying the at-
risk population and targeting these groups constitute the
standards of best practices for developing psychosocial
interventions [35]. Such interventions may focus on self-
efficacy enhancement [20].
Importantly, data referring to gender and self-reported
immediate family cancer history are easy to measure and
obtain, compared to variables which require complex
measurement and interpretation (e.g., psychosocial re-
source variables). The use of gender and family cancer his-
tory as screening criteria should be brief and easy, and
therefore, facilitate the screening process for both patients
and healthcare professionals.
Regardless of its limitations, our study provides novel evi-
dence and explains trajectories of QOL-lung cancer physical
symptoms and self-efficacy among patients with NSCLC.
These trajectories were unfavorable among women with
family cancer history. Gender and family cancer history may
be considered basic screening criteria for identifying groups
of patients at risk for poorer physical QOL (higher level of
physical symptoms related to lung cancer) and lower incline
of self-efficacy after cancer surgery.
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